Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
Clinical trial NCT00375193 · COMPLETED
Trial details
- NCT number
- NCT00375193
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-05-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.